The eflFects of enflurane on certain respiratory characteristics were compared with those of halothane in 70 patients during anaesthesia with spontaneous breathing using a specially designed circuit. The rate of respiration with enflurane (mean 22b.p.m.) was slower than with halothane (mean 31 b.p.m.; / > <0.001) and the tidal volume greater (enflurane mean 240 ml, halothane 180 ml; P<0.05). There was no statistically significant difference in the minute volume of ventilation or end-tidal carbon dioxide concentration between the two agents. The effects of a narcotic premedication were observed in 16 patients in the study. The main effect was to produce slowing of respiratory rate (enflurane mean 16 b.p.m.; halothane 18 b.p.m.). The value of the respiratory pattern compared with the measurement of heart rate and arterial pressure as a clinical guide during anaesthesia is discussed.
The eflFects of an anaesthetic agent on breathing are of obvious clinical importance. The results of many investigations are difficult to relate to clinical practice either because an unusual technique of anaesthesia was used, for example a gaseous induction with oxygen as the only carrier gas, or because the results were obtained from patients who were not being subjected to surgical stimulation (Devine, Hamilton and Pittinger, 1958; Deutsch et al., 1962; Munson et al., 1966; Helrich and Cascorbi, 1969; Bahlman et al., 1972; Hickey et al., 1973; Pietak et al., 1975; Calverley et al., 1978) . The obvious eflFects of surgery on ventilation limit the clinical, as opposed to pure pharmacological, usefulness of such work . A few studies (Holmdahl and Payne, 1960; Wahba, 1979; Wahba and Sadkova, 1979) have used a more standard method of anaesthesia and surgery, but the patients received narcotic premedication which modifies the respiratory eflFects produced by the volatile agent. In addition, all the studies quoted have measured expired volumes with a Wright respirometer which is inaccurate especially during the low gas flows encountered during spontaneous respiration in the anaesthetized patient (Nunn and Ezi-Ashi, 1962; Bushman, 1979) .
This study compared enflurane with halothane when the agents were given as part of a commonly used technique of anaesthesia. Measurements were made during surgery using a breathing system which allowed inspiration (the active part of breathing) to be monitored continuously.
PATIENTS AND METHODS
Seventy patients without clinical evidence of cardiorespiratory disease were studied. The patients were allocated to two groups. Group A was anaesthetized using only one volatile agent, enflurane or halothane, throughout operations on the body surface. Group B received both agents in a crossover study during a single anaesthetic for orthopaedic procedures, half the patients receiving enflurane as the first agent and the other half halothane. A further group of 16 patients was anaesthetized as in group A but received morphine lOmg and cyclizine 50mg i.m. 1 h before induction of anaesthesia (mean 55 min, range 35-65).
Anaesthesia
Patients in groups A and B were premedicated with either promethazine 50 mg orally on the night before surgery or diazepam 10 mg orally or i.m. 2 h before surgery. Both premedicants have been shown to have no significant effect on breathing with the doses used (Steen et al., 1966; Soroker et al., 1978) . 0.6 mg was administered i.v. and was induced with thiopentone i.v. Suxamethonium 0.75-i.v. was given to facilitate tracheal Some patients received lignocaine © Macmillan Publishers Ltd 1981 Atropine anaesthesia 2-4mgkg~1 l.Omgkg" 4% as topical anaesthesia to the larynx. Following orotracheal intubation with a cuffed tube, the patient's ventilation was assisted until spontaneous breathing returned. During the early stages of the study, six patients (three enflurane, and three halothane) did not have a tracheal tube; a close fitting mask was used.
When a satisfactory depth of anaesthesia had been achieved using one of the agents to be studied, the patient was transferred to the operating theatre. Anaesthesia was maintained with a mixture of 60% nitrous oxide in oxygen, delivered from a calibrated monitored dial mixer (Quantiflex B.O.C.) through calibrated vaporizers (Fluotec Mark III, or Enflurotec, Cyprane Ltd) using a specially designed circuit.
Administration of anaesthesia was supervised by one of five consultant anaesthetists who took no other part in the investigation. The depth of anaesthesia was assessed from changes in the heart rate, arterial pressure, pupils, breathing (movement of the reservoir bag) and absence or presence of movement to surgical stimulus. The minimum vapour concentration required to provide adequate surgical anaesthesia was used.
Circuit description
Amodified B.O.C. Mk III circle absorber system was adapted to include a bag-in-bottle. The cannister was removed and a Perspex cylinder substituted. A 2-litre reservoir bag was connected to the gas outlet in the circle head and a pneumotachograph connected to the bottom inlet port. The circle was sealed in the "closed circuit" position, fresh gas flow inlet blocked and the expiratory spill valve modified to a blow-off valve D set at 40cmH 2 O. (fig. 1) .
The circle system was supplied with fresh gas. The fresh gas flow was controlled by Quantiflex flowmeters to allow adjustment of flow without alteration of gas mixtures. On entering the circuit, gas collects in the reservoir limb, internal volume 550 ml, and is prevented from entering the reservoir bag by weighted valve C. The latter valve requires an opening pressure of 2cmH 2 O. The necessary opening pressure is generated during expiration when the Aga poly-valve, A, is partly closed by the expiratory flow. The continuing fresh gas flow and that fresh gas collecting in the reservoir limb is blown through the weighted valve into the reservoir bag. Mixing of the fresh gas with expired gas is prevented by the length of interpos- ing reservoir limb and by the continuous inflow of the fresh gas. On completion of expiration, weighted valve C, expiratory valve B and the poly valve A close thus permitting the patient to inspire only through valve E and hence from the reservoir bag-inbottle. Emptying of the bag causes air to be entrained through the pneumotachograph head F and hence the inspiratory volumes may be measured.
During expiration, valve E closes and the expired gas partially closes the poly valve A, as mentioned previously and, acting as an air piston, pushes fresh gas along the reservoir limb. It is subsequently spilt via valve A during the inspiratory period as the reservoir limb fills with incoming fresh gas. The surplus of expired gas leaves the circuit via an M.I.E. scavenging valve B. The latteT valve is carefully set to an opening pressure 2.5cmH 2 O. A "Mercury" M8 manometer was used to monitor the circuit pressure at this point.
Once the system was adjusted to prevent rebreathing, frequent samples were taken from the inspiratory limb and analysed using a Beckmann LB2 for the presence of carbon dioxide to ensure the absence of rebreathing during its use on patients. The fresh gas flow and expiratory valve B were adjusted so that the reservoir bag was little more than half full at any one time. This ensured that the weighted valve C remained closed during inspiration, preventing augmentation of inspiratory volumes by fresh gas flow.
Using a mass spectrometer to analyse the gas mixture of the inspiratory limb of the circle and using tracer gases in a model lung system, it was found that rebreathing and fresh gas flow augmentation did not produce a significant error (<5% of inspired gas volume) up to minute volumes of 15 litre min"
1 . Tidal volumes ranging from 60 ml to 600 ml could be accurately measured to within ± 2\% at the measured volume. In order that the electrospirometer accurately measured tidal volumes within the normal clinical range, it was specially modified electronically and calibrated for a linear response to flows of 2-40 litre min~' and to tidal volumes less than 600 ml at the cost of a small error (<5%) at volumes over this value.
Electrospirometry
The inspiratory flow pattern, tidal volume and predicted respiratory rate were monitored with an electrospirometer (Mercury CS6), which had been modified by the manufacturers to provide greater accuracy over the range of values found in a pilot survey. Tidal volume and predicted respiratory rate were recorded continuously on a potentiometric flat-bed recorder (Rikadenki-Mitsui DBE-2). The predicted respiratory rate is a computed figure. The electrospirometer is constructed to time from the start of one breath to the start of the next, to calculate a rate from this and to display this rate as if continued for 1 min. A daily calibration of the electrospirometer was performed against an accurate 500-ml gas syringe (Hamilton).
The inspiratory flow pattern was recorded at a fast chart speed for four to six breaths every 5 min on one of the two channels of a pen recorder (Devices MX212). This enabled analysis of the respiratory pattern to be made and flow times to be calculated. The end-tidal carbon dioxide concentration was recorded on the second channel of the pen recorder.
Gas and vapour sampling
The carbon dioxide concentrations were measured with a Beckmann LB-2 infra-red analyser sampling from four to six breaths every 5 min at a flow of 500 ml min" ' through a fine catheter introduced to the endotracheal tube. The carbon dioxide analyser was calibrated against certified cylinders (B.O.C.) and further checked against a mass spectrometer (Medishield MS2).
The analyser head was filled with 100% nitrous oxide surrounding the sample cell to minimize interference as a result of the presence of this gas in the respired mixture. A calibration curve was then constructed, of varying concentrations of carbon dioxide in the presence of nitrous oxide.
The inspiratory and end-tidal concentrations of the volatile agent were monitored continuously with an anaesthetic gas monitor (W.T.I. Type A.G.101) for each agent in 20 patients. The monitor was calibrated against an accurate standard made in a gas calibrator (W.T.I., A.C.201) using a volumetric technique, correcting for variations in ambient temperature and pressure. The inspired and end-tidal volatile agent concentrations were then continuously recorded on a second potentiometric recorder (Rikidenki-Mitsui DBE-2). The vaporizer performance was checked at the beginning and end of the operation against the anaesthetic gas monitor.
Blood-gas analysis
Arterial blood samples were taken if the patient had a respiratory rate of more than 30b.p.m. or if the carbon dioxide analyser did not register a "plateau". These samples were analysed within 5 min of withdrawl with a Radiometer ABL2 blood-gas analyser.
Cardiovascular monitoring
E.c.g. (lead II) was monitored continuously on an oscilloscope (Roche 125). A continuous record was made of the heart rate on a second pen recorder (Devices MX212) from a commercial pulse monitor applied to the finger.
The systolic arterial pressure was measured using an oscillotonometer and recorded at intervals of 5 min. Simultaneously, a note was made of the pupil and eye signs of anaesthesia, Iachrymation, skin colour and capillary filling.
RESULTS
The results were taken when the patients were stable, judged by the respiratory and cardiovascular recordings during surgery and after at least 30 min of anaesthesia. The results for the respiratory variables are the mean of the values obtained during a period of 20 s measured from the continuous recordings for each patient. The data thus provide between-patient comparison. The data on the effects of surgical stimulation refer to within-patient comparison.
All volumes recorded have been converted to b.t.p.s. Statistical analysis was effected by one-way analysis of variance and least squares regression. Table I gives the data for each group by age, sex, weight and height. The patients in the double agent group are older and smaller than the group A patients; this was dictated by the type of procedure being performed, namely orthopaedic operations.
The results of the respiratory measurements are shown in table II. There is significant reduction (P<0.001) in the rate of respiration associated with the use of enflurane compared with halothane. The difference in the tidal volumes between the two agents is also statistically significant (P<0.05). Despite these differences, however, there is no statistical difference between the agents in the minute volume (P = 0.38) or the end-tidal carbon dioxide concentrations (P = 0.79). The ranges of rate, tidal volume, minute volume and end-tidal carbon dioxide tensions are presented in figure 2. The minute volumes recorded are similar except for three patients in the halothane group who had a large minute volume associated with a rapid respiratory rate.
Arterial blood samples taken from eight patients receiving halothane and exhibiting tachypnoea (30 or more b.p.m.), showed a mean difference between end-tidal and arterial tension of only 0.28 kPa. There was thus apparently no great difference between alveolar and arterial tensions of carbon dioxide, even when the respiratory rate was 30-40b.p.m.
The influence of narcotic premedication is indicated by the results from table III. The values for statistical significance were obtained by comparing the results with those obtained from the patients who did not receive narcotic premedication. The narcotic produces slowing of the breathing rate, which is more marked in the case of halothane. There was also a larger mean tidal volume in the halothane group. Despite an increase in tidal volume, there was a significant reduction in minute volumes because of the slower rate. There was a greater end-tidal carbon dioxide concentration, although this was not statistically different, possibly because of the small numbers of patients in the group receiving a narcotic.
It has been suggested that narcotic premedication should be used with enflurane because of the poor postoperative analgesia provided by the agent and the comparatively rapid recovery compared with halothane. During this investigation, however, severe respiratory depression was observed. One patient, a healthy male, age 38 yr, weight 77.3 kg, received morphine 15mg with cyclizine, observed, associated with an end-tidal carbon dioxide tension of 8.5 kPa. With both agents, but notably with enflurane, a wide variation in the concentration of the volatile agent was necessary to produce the required depth of anaesthesia. The range of vaporizer settings and the inspiratory and end-tidal concentrations of these volatile agents monitored in 20 patients receiving halothane and 20 receiving enflurane are shown in figure 3 .
The flow pattern was analysed. The total time for each breath (T l0 J, inspiratory time (Ti) and expiratory time (TE) were derived by measuring the time from zero flow ( fig. 4) The peak inspiratory flow rate was measured from the chart recording. The inspiratory flow patterns were recorded for each agent from 20 patients and the results, including the derived values VijTi and Ti/T tol , are presented in table IV. None of the patients from whom these flow patterns were recorded received a narcotic premedication. Changes in heart rate and systolic arterial pressure were most marked at the time of the first surgical stimulus. Only small increases occurred in heart rate and arterial pressure during enfiurane anaesthesia (table V) .
A greater increase in the heart rate and arterial pressure occurred during halothane, and only during halothane anaesthesia did the increase reach statistical significance.
The effects of surgical stimulation on the respiratory rate and tidal volume are shown in table VI. The tidal volume increased significantly with both agents, but the respiratory rate changed only with halothane anaesthesia. The reduced number of patients in the enfiurane group is because of the exclusion of four patients; all had tidal volumes greater than 300 ml before stimulation but moved in response to the surgical stimulus and required increased inspired vapour concentrations. 
Method
Accurate continuous measurement of tidal volume is difficult to achieve whilst administering anaesthesia through conventional breathing systems. The Wright respirometer is the most commonly used device for such measurements and until recently could not be used to provide a continuous record; thus a series of measurements had to be taken and a mean value calculated. Sighs during normal breathing would thus be missed or, if included, result in a misleading high mean value. Further, the accuracy of the Wright varies with humidity, temperature, high or low gas flows and gas composition (Bushman, 1979) .
A wet spirometer has been used to monitor tidal volumes (Nunn and Matthews, 1959 ), but we found considerable inaccuracy when attempting to measure small tidal volumes (< 150ml) at rapid rates (40b.p.m.) which may occur, for example, during halothane anaesthesia. The large internal volume of the system and inertia of the bell movement caused an underestimate of the true tidal volume.
Impedance pneumography and other indirect methods of tidal volume measurement present technical difficulties in calibration during clinical anaesthesia.
A pneumotachograph may be used within the circuit, but the varying gas composition observed during clinical anaesthesia introduces an error that can only be partly compensated for by pre-calibration with a known gas mixture. Humidity and temperature variation such as occur within an anaesthetic circuit also cause inaccuracies during continuous measurement, as would the large deadspace of the electrospirometer head, if this were directly interposed into the system. The potential sensitivity, accuracy and low resistance of a pneumotachograph, however, makes it an ideal tool for continuous respiratory measurement. If a displacement system is interposed between the pneumotachograph head and the anaesthetic gases, the problems can be eliminated because room air can be used for calibration.
In this study we wished to control the inspired vapour concentrations in a manner similar to that when using a Magill system. Observing the displacement produced by a bag-in-bottle attached to a totally closed system was therefore of no value. Balancing the fresh gas flow through a nonrebreathing system during the varying depths of respiration observed in surgical anaesthesia also proved impractical. Furthermore, the actuating and slip volumes required by most non-rebreathing valves are significant when measuring small tidal volumes.
We have designed a circuit which separates the inspiratory and expiratory pathways and, in that respect, it resembles a non-rebreathing circuit. A feedback mechanism regulating the filling of the reservoir bag compensates for changes in the depth of breathing and hence the reservoir bag contains a constant volume before each inspiratory period. Gas flow is prevented from entering the reservoir bag during inspiration by a weighted valve C in the fresh gas line. This valve opens only during the expiratory period when the fresh gas flow is augmented by the expiratory gas flow from the patient.
The inspiratory emptying of the reservior bag within the bag-in-bottle system causes room air to be entrained through the pneumotachograph. Hence, continuous observation of the inspired flow pattern is possible.
Respiratory effects
The main difference between the two agents is the effect on the rate of breathing; enflurane being associated with a lower, nearly normal rate. The tidal volume during enflurane administration is greater than that observed during halothane anaesthesia. The results for minute volume and endtidal carbon dioxide are similar for the agents.
If the results of the timing of respiration, in table IV, are expressed in a graphical form, two inferences may be drawn. First, even though there is marked tachypnoea during halothane anaesthesia, the relationship between the inspiratory time (T\) and the expiratory time (TE) of the respiratory cycle appears to be the same for both agents ( fig.  5 ). This is in contrast to other techniques of anaesthesia such as neuroleptanalgesia in which rate changes occur at the expense of the expiratory period (Prys-Roberts and Kelman, 1967) . Second, the relationship between the inspiratory time (Ti) or expiratory time ( TE) and the total time of the respiratory cycle (T i( J is also the same for both agents used in this study ( fig. 6 ). The calculated slopes of the regression lines are almost identical to values found in normal, awake resting humans (Bendixen, Smith and Mead, 1964 ). This appears to suggest an extension of the normal rate control mechanisms even during the marked tachypnoea seen with halothane. Previous reports mentioned the sighing respiration, seen during enflurane anaesthesia. This seems also to be a part of the normal pattern of awake respiration (Bendixen, Smith and Mead, 1964) , and occurred in approximately 75% of the patients in this study; in 25% this was regular with a periodicity between 2 and 11 min. Sighs were also recorded in about 5% of the patients in the halothane group, although smaller and irregular. Sighing was not observed in any patient who had received narcotic premedication, although it is a well-recorded phenomenon during anaesthesia with ethers. In contrast, tachypnoea appears to be associated with the halogenated hydrocarbons (Dundee, 1953; Derenne et al., 1978) .
Depth of anaesthesia
No single clincial criterion can be shown always to correlate with the depth of anaesthesia (Cullen et al., 1972) , but the combined clinical criteria of stable heart rate, arterial pressure, pupil and eye signs, with absence of lachrymation or reaction to surgical stimulation, are the variables used by the anaesthetist to assess depth. These criteria were used in this study whilst using the lowest concentration of volatile agent practicable.
The concept of minimum alveolar concentration (MAC) (Eger, Saidman and Brandstater, 1965) overcomes some of the problems of inter-agent concentration comparison, but there are difficulties when multiples of MAC are used, as must be the case in a clinical investigation. First, there is an error of 10% in the values quoted for MAC (Eger, Saidman and Brandstater, 1965; Cullen and Egar, 1971) leading to the possibility of larger errors on multiplication. Second, to assume that a multiple of one MAC is equipotent with the same multiple of MAC with another agent assumes the two dose-response curves are parallel. There has been criticism of this assumption (Waud and Waud, 1970) . Indeed, it has been suggested, after mathematical analysis of the data on MAC, that the dose-respone curves for halothane and enflurane are not of similar slope (de Jong and Eger, 1975) .
Nevertheless, there is no significant difference between the equivalent mean concentrations of halothane and enfiurane used in this study (halothane 1.44±0.05 MAC, enfiurane 1.31 ±0.07 MAC). The accepted value of MAC for enfiurane is 1.68% v/v (Gion and Saidman, 1971 ) and for halothane 0.77% v/v (Dripps, Eckenhoff and Vandam, 1972) . A correction has been made for age (Gregory, Eger and Munson, 1969) and the presence of 60% nitrous oxide (Saidman and Eger, 1964) .
Most clinical criteria used to assess depth of anaesthesia depend on autonomic nervous system activity and many variables interact with the anaesthetic agent used to alter such activity. Respiratory signs of rate and tidal volume are less affected by autonomic activity and may provide a better index of depth of anaesthesia.
Enfiurane anaesthesia is associated with a stable cardiovascular system and marked meiosis (Black, Johnston and Scott, 1977) . The results presented in tables III, V and VI demonstrate that the tidal volume is the only variable to be altered significantly following surgical stimulation whilst administering enfiurane. In contrast, tidal volume, respiratory rate and systolic arterial pressure are all altered during halothane administration. Further, during enfiurane anaesthesia a much wider range of vaporizer settings is required to produce satisfactory anaesthesia than with halothane. Unnecessarily high concentrations may therefore be given during enfiurane anaesthesia, causing marked respiratory depression.
Continuous monitoring of the tidal volume may provide the best index of the depth of anaesthesia whilst also preventing the administration of too great a concentration of volatile anaesthetic. 
SUMARIO
Se compararon los efectos de la cnflurano en ciertas caracteristicas respiratorias, en relation a los del halotano, en 70 pacientes bajo anestesia, con respiracion espontanea y usando un circuito especialmente disenado. El regimen de la respiracion con enflurano (media de 22 r.pjn.) fue mas lento que con halotano (media dc 31r.p.m.; P<0,001) y el volumen penodico fue superior (media para enflurano de 240 ml, media para halotano de 180 ml; P<0,05). No existdo una diferencia estadistica significative en el diminuto volumen dc ventilacion ni en la concentration de dioxido de carbono al termino del periodo entre los dos agentes. En 16 de los pacientes del estudio se observaron los efectos de una premedicacion de caracter narcorico. El cfecto principal fue la reduction del regimen de la respiracion (media de 16r.p.m. para el cflurano y de 18r.p.m. para el halotano). El valor del modelo respiratorio en comparacion con la medicion del ritmo cardiaco y de la presion arterial, como guia clinica durante la anestesia, veine discutido.
